Standard Lithium To Acquire Lithium Brine Exploration And Production Rights
August 2, 2017 – Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLL FRA:S5L OTCQX:STLHF) is pleased to announce that the Company has entered into a Memorandum of Understanding (MoU) with a non-affiliated NYSE-listed company with regard to an option to acquire certain rights to conduct brine exploration and production and lithium extraction activities on approximately 30,000 net brine acres in exchange for a cash payment of US$500,000, with additional fees and payment obligations in the future if the option is executed and exercised, and subject to certain conditions. The brine leases overlie the Smackover Formation in a region with a long history of commercial scale brine processing.
Review of historical published brine data from within and adjacent to the lease area leads the Company to believe that lithium-bearing brines are likely present, though further work will be conducted during the due-diligence period to confirm this.
Closing of the transaction contemplated by the MoU is contingent on the completion of satisfactory due diligence work and studies as well as the finalization of a definitive agreement between the two parties. The Company will provide further information on the transaction as it becomes available.
On behalf of the Board,
Standard Lithium Ltd.
Robert Mintak, Director & CEO
About Standard Lithium
Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovation & results oriented management team with a strong focus on technical skills. The Company is currently focused on the immediate exploration and development of its 16,000+ acre Bristol Lake, Brine Project located in the Mojave region of San Bernardino County, California. The location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities.
For further information, contact Anthony Alvaro at 604.260.4793
As lithium demand grows, a number of investors have gone into investing in lithium. Demand for the commodity has been spiking recently thanks to the popularity of lithium-ion batteries. As such, some investors have turned ... [Read]
Two things are happening right now that investors should have on their radars. The first is that some microcap stocks are doing very well. This is evidenced in part by the iShares Microcap ETF (IWC) ... [Read]
VANCOUVER, BC, Oct. 26, 2021 /PRNewswire/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in ... [Read]
Just over a week in November, and with the clocks going back and the dark evenings setting in, we’ve brought you some penny stock picks to bring some light to your investment portfolio. Penny stocks ... [Read]
Every day, fears about the trade war and an ensuing recession have analysts feeling increasingly bearish about the economy. But whenever the rest of the market looks like dirt, there’s one sector that glints brightly ... [Read]
EROS stock is a notable penny stock gainer in Thursday’s session as Eros International plc (NYSE:EROS) and Microsoft (NASDAQ:MSFT) have agreed to build a next-gen online video platform on Azure. Investors Cheer the News When ... [Read]
Making money on the stock market isn’t all about investing in big tech stocks like Amazon, Microsoft, Google, or Facebook. Sometimes it can be far more beneficial to target smaller, niche-focused corporations that have the ... [Read]
Vancouver, British Columbia–(Newsfile Corp. – February 13, 2019) – LOOPShare Ltd. (TSXV:LOOP) (OTC Pink:LPPPF), world’s first fully-integrated electric scooter sharing platform, has begun a worldwide expansion of its Loop™ micro-mobility rideshare system with the purchase ... [Read]
Antibe Therapeutics to Present at the 11th Annual LD Micro Main Event on December 4, 2018 Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV:ATE, OTCQB:ATBPF), a leader in developing safer therapeutics for pain and inflammation, ... [Read]
Disclosure:
1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.
2) The Article was issued on behalf of a third party, Standard Lithium Ltd. Market Jar Media Inc. has or expects to receive the following amounts from Native Ads Inc. in the amount of one hundred nineteen thousand, eight hundred forty seven canadian dollars for 185 campaign days (127 business days).
3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.
4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Market Jar Media Inc. should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Market Jar Media Inc.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.
